Advertisement

Detection of carbon disulfide in breath and air: a possible new risk factor for coronary artery disease

  • Michael Phillips
Article

Summary

Carbon disulfide (CS2) is toxic to the heart and arteries; chronic exposure can result in accelerated atherosclerosis and coronary artery disease in humans and animals. Exposure to CS2 was investigated in normal volunteers working in New York City, using a new and highly sensitive assay. Volatile organic compounds in breath and air were captured in adsorbent traps containing graphitized carbon and molecular sieve, then thermally desorbed, concentrated by two-stage cryofocusing, and assayed for CS2 by gas chromatography/mass spectroscopy. Breath CS2 assays were performed in 42 normal volunteers, as well as in room air and in outdoor air collected at sites in and around New York City. The assay was linear, reproducible, and sensitive to picomolar (10−12 mol/l) quantities. CSZ was detected in all samples of breath and indoor and outdoor air (mean concentrations were 5.25 pmol/l, SD = 3.89 in breath, 8.26 pmol/l in indoor air, and 3.92 pmol/l in outdoor air) (NS). The alveolar CS2 gradient (alveolar — inspired CS2) ranged from −20.0 to 8.0 nmol/l, separating subjects into either “excreters” or “retainers” of CS2. In view of the known toxicity of CS2, atmospheric pollution with CS2 merits attention as a possible new risk factor for the development of accelerated atherosclerosis and coronary artery disease.

Key words

Air assays Atherosclerosis Breath assays Carbon disulfide Coronary artery disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Davidson M, Feinleib M (1972) Carbon disulfide poisoning: a review. Am Heart J 83:100–114Google Scholar
  2. 2.
    Schilling RSF (1970) Coronary heart disease in viscose rayon workers. Am Heart J 80:1–2CrossRefGoogle Scholar
  3. 3.
    Beauchamp RO Jr, Bus JS, Popp JA, Boreiko CJ, Goldberg L (1983) A critical review of the literature on carbon disulfide toxicity. Crit Rev Toxicol 11:169–278PubMedGoogle Scholar
  4. 4.
    Tiller JR, Schilling RSF, Morris JN (1968) Occupational toxic factor in mortality from coronary heart disease. Br Med J 4:407–411PubMedGoogle Scholar
  5. 5.
    Tolonen M, Nurminen M, Hernberg S (1979) Ten-year coronary mortality of workers exposed to carbon disulfide. Scand J Work Environ Health 5:109–114PubMedGoogle Scholar
  6. 6.
    Nurminen M, Hernberg S (1985) Effects of intervention on the cardiovascular mortality of workers exposed to carbon disulphide: a 15 year follow up. Br J Ind Med 42:32–35PubMedGoogle Scholar
  7. 7.
    Sweetnam PM, Taylor SWC, Elwood C (1987) Exposure to carbon disulphide and ischaemic heart disease in a viscose rayon factors. Br J Ind Med 44:220–227Google Scholar
  8. 8.
    Vermel AE, Nikitina LC, Gasanian G, Schatskaja NN (1986) Incidence of ischemic heart disease and arterial hypertension among persons exposed to carbon disulfide. Terapeuticheskii Arkhiv 58(12):35–39Google Scholar
  9. 9.
    MacMahon B, Monson RR (1988) Mortality in the US rayon industry. J Occup Med 30:698–705PubMedGoogle Scholar
  10. 10.
    Nicrosini F, Pasotti C, Del Favero A, Ricotti V, Marchesi E (1963) Hematic, hepatic, and aortal lipids in chronic experimental intoxication with carbon disulfide in rabbits. Action of extractive duodenal heparinoid. Arch Sci Med 115:109Google Scholar
  11. 11.
    Wronska-Nofer T, Szendzikowski S, Laurman W (1978) The effect of carbon disulfide and atherogenic diet on the development of atherosclerotic changes in rabbits. Atherosclerosis 31:33Google Scholar
  12. 12.
    Wronska-Nofer T, Szendzikowski S, Obrebska-Parke M (1980) Influence of chronic carbon disulphide intoxication on the development of experimental atherosclerosis in rats. Br J Ind Med 37:387Google Scholar
  13. 13.
    Hoffmann P, Klapperstuck M (1990) Effects of carbon disulfide on cardiovascular function after acute and subacute exposure of rats. Biomed Biochim Acta 49:121–128PubMedGoogle Scholar
  14. 14.
    Rosier J, Veulemans H, Masschelein R, Vanhoorne M, Van Peteghem C (1987) Experimental human exposure to carbon disulfide. I. Respiratory uptake and elimination of carbon disulfide under rest and physical exercise. Int Arch Occup Environ Health 59:233–242Google Scholar
  15. 15.
    Herrmann G, Leuschke W, Viehrig J (1989) On the inhalant reception of carbon disulfide — studies of carbon disulfide intake with dynamic offered doses during 4 hours. Z Gesamte Hyg 35:537–541Google Scholar
  16. 16.
    Lam CW, DiStefano V, Morken DA (1986) The role of the red blood cell in the transport of carbon disulfide. J Appl Toxicol 6:81–86Google Scholar
  17. 17.
    Rosier JA, Van Peteghem CH (1987) Determination of toxicologically important partition coefficients of carbon disulphide by means of the vial equilibration method. Br J Ind Med 44:212–213Google Scholar
  18. 18.
    McKenna MJ, DiStefano V (1977) Carbon disulfide. I. The metabolism of inhaled carbon disulfide in the rat. J Pharmacol Exp Ther 202:245–252PubMedGoogle Scholar
  19. 19.
    Campbell L, Jones AH, Wilson HK (1985) Evaluation of occupational exposure to carbon disulphide by blood, exhaled air, and urine analysis. Am J Ind Med 8:143–153PubMedGoogle Scholar
  20. 20.
    Rogers WK, Wilson M, Becker CE (1978) Methods for detecting disulfiram in biologic fluids: application in studies of compliance and effect of divalent cations on bioavailability. Alcohol Clin Exp Res 2:375–380Google Scholar
  21. 21.
    Rychtarik RG, Smith PO, Jones SL, Doerfler L, Hale R, Prue DM (1983) Assessing disulfiram compliance: validational study of an abbreviated breath test procedure. Addict Behav 8:361–368CrossRefPubMedGoogle Scholar
  22. 22.
    Phillips M, Greenberg J, Martinez V (1986) Measurement of breath carbon disulfide during disulfiram therapy by gas chromatography with flame photometric detection. J Chromatogr 381:164–167Google Scholar
  23. 23.
    Phillips M, Greenberg J (1991) A method for the collection and analysis of volatile compounds in the breath. J Chromatogr 564:242–249Google Scholar
  24. 24.
    Morris C, Berkley R, Bumgarner J (1983) Preparation of multicomponent volatile organic standards using static dilution bottles. Anal Lett 16(A20):1585–1593Google Scholar
  25. 25.
    Ruijten MWMM, Salle HJA, Verberk MM, Muijser M (1990) Special nerve functions and colour discrimination in workers with long term low level exposure to carbon disulphide. Br J Ind Med 47:589–595Google Scholar
  26. 26.
    Steinberg D (1990) Lipoproteins and atherogenesis. Current concepts. JAMA 264:3047–3052PubMedGoogle Scholar
  27. 27.
    Laurman W, Salmon S, Maziere C, Maziere J-C, Auclair M, Theron L, Santus R (1989) Carbon disulfide modification and impaired catabolism of low density lipoprotein. Atherosclerosis 78:211–218Google Scholar
  28. 28.
    Herrick JB (1912) Clinical features of sudden obstruction of the coronary arteries. JAMA 59:2015–2020Google Scholar
  29. 29.
    Harrison TR, Reeves TJ (1968) Highlights in the history of ischemic heart disease. In: Principles and problems of ischemic heart disease. Year Book Medical, Chicago, pp 25–30Google Scholar
  30. 30.
    Kannel WB, Thom TJ (1968) Incidence, prevalence, and mortality of cardiovascular diseases. In: Principles and problems of ischemic heart disease. Year Book Medical, Chicago, pp 627–638Google Scholar
  31. 31.
    Barney GO (ed) (1982) The Global 2000 Report to the President, vol 1, Chap 13. Environmental projections. Penguin, New York, pp 221–446Google Scholar
  32. 32.
    Stamler J (1985) The marked decline in coronary heart disease mortality rates in the United States, 1968–1981; summary of findings and possible explanations. Cardiology 72:11–22PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Michael Phillips
    • 1
  1. 1.Department of MedicineSt. Vincent's Medical Center of RichmondStaten IslandUSA

Personalised recommendations